After more than half a year of renovation, Fujian Huakang Pharmaceutical Co., Ltd. has built a thousand ton chitin production line. According to professionals who have visited and inspected similar international production enterprises, the production scale, process technology, and quality level of this production line have leapt to the "international first-class" level. Currently, we are providing chitosan, a marine biological product necessary for glucosamine hydrochloride products to enterprises such as Cheng Yi Pharmaceutical.
Attendees take a group photo at Huakang Company as a souvenir
On July 17th, Zhejiang Cheng Yi Pharmaceutical Co., Ltd. held a semi annual production and operation meeting at its controlling subsidiary, Fujian Huakang Pharmaceutical Co., Ltd. Before the meeting, Nie Wenbin, General Manager of Fujian Huakang Company, led the attendees to visit the chitin production line. According to Nie Wenbin, Huakang Company is located in Jintang Industrial Park, Shaowu City, Fujian Province, and is a provincial-level circular economy demonstration industrial park. In November 2018, Cheng Yi Pharmaceutical Holdings Fujian Huakang Company began laying out a 1000 ton chitin production project, which was completed and put into operation by October 2019. At present, Fujian Huakang Company specializes in the research and development, production, sales, and service of chitin and its derivatives. Its main products include glucosamine hydrochloride, glucosamine potassium sulfate, glucosamine sodium sulfate, chitosan, and other series of products.
Visiting the Shell Production Line of Huakang Company
The semi annual production and operation closed door meeting of Cheng Yi Pharmaceutical was held for a whole day. General Manager Zhao Chunjian presided over the meeting. In the summary stage of the meeting, Chairman Yan Yiyi pointed out that he was pleased to see the chitin production line of Fujian Huakang Company. The management team of Fujian Huakang Company worked hard, laying a solid foundation for Cheng Yi Pharmaceutical to expand and strengthen the flagship product of "glucosamine hydrochloride" and improve the industrial chain. Mr. Yan pointed out that enterprises should make more arduous efforts in business model, quality management, technological innovation, production scale, product structure and talent management in order to comprehensively improve their competitiveness. The reason why this meeting was chosen to be held at the subsidiary of Fujian Huakang is to show everyone their strengths and encourage them; We also need to understand our own shortcomings and find gaps.
General Manager Zhao presided over the meeting, while Chairman Yan gave a concluding speech
popular science knowledge
What is chitin:
In 1823, French scientist Odell extracted chitin from crustacean marine organisms. Odell has been proved through long-term and extensive experiments that chitin can reduce the attack rate of arthritis and relieve the pain of arthritis. Oudell named it "D-glucosamine" or aminosugar for short. In 1969, Germany first clinically validated that glucosamine can effectively treat osteoarthritis. After nearly 200 years of development, scientists generally believe that chitin can also inhibit cancer and tumor cell metastasis, improve human immunity, and protect the liver and detoxify.
The "Weigu" brand of glucosamine hydrochloride produced by Cheng Yi Pharmaceutical is made from chitin extracted from crustaceans such as marine shrimp and crabs. Its stability and purity of glucosamine are superior to that of glucosamine sulfate products, and it has advantages and characteristics such as pure natural marine drugs, no excipients or additives, complete domestic specifications, and dual approval documents for raw materials and formulations.